Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating adhesion molecules in disease

A J Gearing1, W Newman

  • 1British Biotechnology PLC, Cowley, Oxfordshire, UK.

Immunology Today
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The transformation of a gold standard in-person substance use assessment to a web-based, REDCap integrated data capture tool.

Journal of biomedical informatics·2019
Same author

Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.

EBioMedicine·2016
Same author

Detection of nitroaromatics in the solid, solution, and vapor phases using silicon quantum dot sensors.

Nanotechnology·2016
Same author

Prevention of breast cancer in the context of a national breast screening programme.

Journal of internal medicine·2012
Same author

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

The HUGO journal·2011
Same author

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.

Health technology assessment (Winchester, England)·2011
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Soluble adhesion molecules, when increased during disease, offer insights into disease progression and pathology. Monitoring these molecules aids in understanding disease prognosis and underlying mechanisms.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Soluble isoforms of adhesion molecules complicate the understanding of lymphoid-endothelial cell interactions.
  • Elevated levels of these soluble isoforms are observed during various disease processes.

Purpose of the Study:

  • To review evidence linking increased circulating soluble adhesion molecules to disease prognosis and pathology.
  • To explore the role of soluble adhesion molecules in disease mechanisms.

Main Methods:

  • Literature review of studies on soluble adhesion molecules.
  • Analysis of data correlating soluble adhesion molecule levels with disease outcomes.

Main Results:

  • Increased levels of circulating soluble adhesion molecules are associated with disease progression.

Related Experiment Videos

  • These molecules may serve as biomarkers for disease prognosis.

    • Conclusions:

    • Soluble adhesion molecules are crucial for understanding lymphoid-endothelial cell interactions in disease.
    • Monitoring soluble adhesion molecule levels can provide insights into disease pathology and patient prognosis.